Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
116 participants
INTERVENTIONAL
2012-10-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Berries and Berry Fractions on Metabolic Diseases
NCT01860547
Comparison of the Effects of Standardized Chokeberry Extracts With Various Formulations on the Levels of Selected Markers Associated With Cardiovascular Disease
NCT05988099
Effects of Tocotrienols Supplementation on Platelet Aggregation in Subjects With Metabolic Syndrome
NCT01631838
Natural Modulators of Immune Function and Mood
NCT05508529
The Influence of Dietary Plant Sterols and Plant Stanols on Cholesterol and Plant Sterol Levels in Atheromatous Plaques
NCT00737919
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sea buckthorn oil
3 g (6 capsules)/day for three months
Sea buckthorn oil
Placebo oil
3 g (6 capsules)/day for three months
Placebo oil
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sea buckthorn oil
Placebo oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 55-75 years of age
* at least 12 months from menstruation
Exclusion Criteria
55 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Finnish Funding Agency for Technology and Innovation
UNKNOWN
Aromtech Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Petra Larmo
R&D manager, Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Risto Erkkola, Professor
Role: PRINCIPAL_INVESTIGATOR
Turun Gynekologikeskus, Turku, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Turun Gynekologikeskus
Turku, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Clinical Study Report
View DocumentOther Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBMM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.